Price T Rowe Associates Inc Asensus Surgical, Inc. Transaction History

Price T Rowe Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.36 - $1.0 $14,508 - $40,300	-40,300 Reduced 17.85%	185,500 $123,000
Q4 2022 Feb 14, 2023	SELL	$0.29 - $0.47 $20,387 - $33,041	-70,300 Reduced 23.74%	225,800 $78,000
Q3 2022 Nov 14, 2022	BUY	$0.38 - $0.73 $32,832 - $63,072	86,400 Added 41.2%	296,100 $134,000
Q2 2022 Aug 15, 2022	SELL	$0.37 - $0.61 $7,859 - $12,957	-21,241 Reduced 9.2%	209,700 $83,000
Q1 2022 May 16, 2022	BUY	$0.53 - $1.19 $17,543 - $39,389	33,100 Added 16.73%	230,941 $145,000
Q4 2021 Feb 14, 2022	BUY	$1.03 - $2.31 $73,130 - $164,010	71,000 Added 55.98%	197,841 $220,000
Q3 2021 Nov 15, 2021	BUY	$1.74 - $2.93 $42,804 - $72,078	24,600 Added 24.06%	126,841 $235,000
Q2 2021 Aug 16, 2021	SELL	$1.52 - $3.62 $1,153 - $2,747	-759 Reduced 0.74%	102,241 $324,000
Q1 2021 May 17, 2021	BUY	$0.9 - $6.32 $92,700 - $650,960	103,000 New	103,000 $335,000

4.03M

Ticker ASXC
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 236,719,008
Market Cap $82.9M
Description
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.